Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1997-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4088/JCP.V58N0702PMID 9269249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluoxetine withdrawal symptoms.

  1996cited by this paper
• Serotonin reuptake inhibitor withdrawal.

  1996cited by this paper
• Possible venlafaxine withdrawal syndrome.

  1996cited by this paper
• Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.

  1996cited by this paper
• Adverse Events After the Abrupt Discontinuation of Paroxetine

  1995cited by this paper
• Suspected congenital sertraline dependence

  1995cited by this paper
• Effects of third trimester fluoxetine exposure on the newborn.

  1995cited by this paper
• Paroxetine withdrawal syndrome.

  1995cited by this paper
• Fluoxetine withdrawal?

  1995cited by this paper
• Holding on: depression, sensitization by antidepressant drugs, and the prodigal experts.

  1995cited by this paper
• A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.

  1995cited by this paper
• Potential Withdrawal Syndrome Associated with Ssri Discontinuation

  1995cited by this paper
• Severe psychiatric symptoms associated with paroxetine withdrawal.

  1995cited by this paper
• Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.

  1995cited by this paper
• Physical symptoms associated with paroxetine withdrawal.

  1995cited by this paper
• A possible paroxetine withdrawal syndrome.

  1995cited by this paper
• Withdrawal syndromes after paroxetine and sertraline discontinuation.

  1995cited by this paper
• Antidepressants in pregnancy and breastfeeding

  1995cited by this paper
• Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study

  1995cited by this paper
• Discontinuation reactions following sertraline.

  1995cited by this paper
• Risks and implications of interrupting maintenance psychotropic drug therapy.

  1995cited by this paper
• Withdrawal reaction after sertraline discontinuation.

  1994cited by this paper
• Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.

  1994cited by this paper
• SSRI withdrawal buzz.

  1994cited by this paper
• Physical symptoms associated with paroxetine discontinuation.

  1994cited by this paper
• Is there a serotonergic withdrawal syndrome?

  1993cited by this paper
• The abrupt discontinuation of fluvoxamine in patients with panic disorder.

  1993cited by this paper
• Fluvoxamine withdrawal syndrome

  1992cited by this paper
• Extrapyramidal symptoms upon discontinuation of fluoxetine.

  1991cited by this paper
• Extrapyramidal symptoms upon discontinuation of fluoxetine.

  1991cited by this paper
• Manic-Depressive Illness

  1990cited by this paper
• Antidepressant withdrawal syndromes: phenomenology and pathophysiology

  1989cited by this paper
• Antidepressant withdrawal syndromes: phenomenology and pathophysiology.

  1989cited by this paper
• Antidepressant withdrawal phenomena.

  1984cited by this paper

• Empty bottles, rising risks: A case-crossover study on psychotherapeutic medication depletion and suicide triggers.

  2025cites this paper
• Serotonergic antidepressants are associated with increased acute bleeding events following femur fracture fixation: A nationwide matched cohort analysis of 5,477 patients.

  2025cites this paper
• Psychopharmacological treatment in patients planned for hip or knee replacement

  2024cites this paper
• Insufficient correctness of package inserts for psychotropic drugs in Germany

  2024cites this paper
• The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.

  2024cites this paper
• Current strategies for tapering psychiatric drugs: Differing recommendations, impractical doses, and other barriers.

  2023cites this paper
• SSRI withdrawal syndrome in children and adolescents: a narrative literature review

  2023cites this paper
• Antidepressant Use During Hospice Patients’ Final Months on Routine Home Care

  2022cites this paper
• The Use of Videogames and Virtual Reality for the Assessment of Anxiety and Depression: A Scoping Review

  2022cites this paper
• Global research production in neonatal abstinence syndrome: A bibliometric analysis

  2022cites this paper
• Antidepressant discontinuation syndrome: A state-of-the-art clinical review.

  2022cites this paper
• Antidepressant discontinuation syndrome (or antidepressant withdrawal syndrome) is triggered by the interruption, reduction or discontinuation of all major antidepressant classes1. Symptoms

  2021cites this paper
• Desvenlafaxine withdrawal serotonergic syndrome in a newborn

  2021cites this paper
• Serotonin Syndrome Associated with Antidepressant Discontinuation in a Neonate Following Drug Exposure During Pregnancy

  2021cites this paper
• How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication

  2020cites this paper
• Clinical Remission of Treatment-Resistant Depression, Polysubstance Abuse, and Antidepressant Discontinuation Syndrome Through Engagement of Lifestyle Interventions.

  2020cites this paper
• Newborn with serotoninergic syndrome due to desvenlafaxine abstinence.

  2020cites this paper
• Update on Pharmacotherapy in Psychodermatological Disorders

  2020cites this paper
• [Review Articles].

  2020cites this paper
• Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

  2020cites this paper
• Effects of Treatment Discontinuation in Clinical Psychopharmacology

  2019cites this paper
• Gaming Disorder

  2019cites this paper
• SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?

  2019cites this paper
• MANAGEMENT OF ANTIDEPRESSANT INDUCED SIDE EFFECTS.

  2019cites this paper
• The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability

  2018cites this paper
• Manic Switch On Mirtazapine: A Case Report

  2018cites this paper
• Pharmacosexology: Psychiatric Side Effects of Drugs for the Treatment of Sexual Dysfunction

  2018cites this paper
• An interesting discontinuation syndrome with citalopram: A case report

  2018cites this paper
• Sexual Dysfunctions in Mentally Ill Patients

  2018cites this paper
• Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?

  2017cites this paper
• Development of a psychologically-based treatment for chronic pain in Singapore : patient and healthcare professional inputs, theoretical model and a feasibility trial

  2016cites this paper
• Association of Selective Serotonin Reuptake Inhibitors with Transfusion in Surgical Patients

  2016cites this paper
• Psychologists’ Views and Experiences of Antidepressant Treatment for Depression

  2016cites this paper
• Psychiatry’s Continuing Expansion of Depressive Disorder

  2016cites this paper
• A review of the management of antidepressant discontinuation symptoms

  2015cites this paper
• Olası Paroksetin Tedavisinin Kesilmesi İle İlişkili İlk Atak Mani

  2015cites this paper
• Pediatric Psychopharmacology for Treatment of ADHD, Depression, and Anxiety

  2015cites this paper
• Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

  2015cites this paper
• New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal

  2015cites this paper
• Citalopram induced nightmare in an elderly man: a case-report

  2015cites this paper
• Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction.

  2014cites this paper
• Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

  2014cites this paper
• Emerging Mania Following Escitalopram Withdrawal

  2014cites this paper
• Managing the Adverse Effects of Antidepressants

  2014cites this paper
• New insights on the antidepressant discontinuation syndrome

  2014cites this paper
• The Use of Animal Models to Measure Tolerance, Dependence, and Abuse Potential

  2014cites this paper
• Chemotherapy in psychiatry

  2013cites this paper
• Treatment of Premature Ejaculation with Dapoxetine

  2013cites this paper
• Antidepressant-Antianxiety Agents

  2013cites this paper
• Distortion, Bias, and Ethical Informed Consent: Presentations of Etiological and Treatment Factors in Abnormal Psychology Textbooks

  2013cites this paper
• Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved

  2013cites this paper
• Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis

  2013cites this paper
• with Withdrawal of Antidepressants

  2013cites this paper
• Mania during antidepressant withdrawal in late‐onset depression

  2013cites this paper
• Selective serotonin reuptake inhibitors and surgery: to hold or not to hold, that is the question: comment on "Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery".

  2013cites this paper
• Prediction and Prevention of Prescription Drug Abuse: Role of Preclinical Assessment of Substance Abuse Liability.

  2013cites this paper
• Mania/Hypomania Associated with Withdrawal of Antidepressants

  2013influential citation
• Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances.

  2013cites this paper
• Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges

  2012cites this paper
• Antidepressants for the Treatment of Chronic Pain

  2012cites this paper
• Psychopharmacological treatment of mood and anxiety disorders during pregnancy.

  2012cites this paper
• Dapoxetine: a new option in the medical management of premature ejaculation

  2012cites this paper
• ANTIDEPRESSANTS AND PANIC DISORDER

  2012cites this paper
• Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder

  2012cites this paper
• Antidepressants and Bleeding Risk After Face-lift Surgery

  2012cites this paper
• Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders

  2012cites this paper
• Paroxetine

  2012cites this paper
• The Regulation of Brain Serotonergic and Dopaminergic Neurons: The Modulatory Effects of Selective Serotonin Reuptake Inhibitors, Atypical Neuroleptics and Environmental Enrichment

  2012cites this paper
• A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature.

  2012cites this paper
• Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.

  2011cites this paper
• Current approaches and issues in non-clinical evaluation of abuse and dependence.

  2011cites this paper
• Efficacy of Dapoxetine in the Treatment of Premature Ejaculation

  2011cites this paper
• Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxide.

  2011cites this paper
• Identification and Treatment of Depression in Minority Populations

  2011cites this paper
• [Perioperative adverse events related to antidepressive agents use].

  2011cites this paper
• How Good Are Current Approaches to Nonclinical Evaluation of Abuse and Dependence?

  2011cites this paper
• The mechanisms of tolerance in antidepressant action.

  2011cites this paper
• Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction.

  2011cites this paper
• Complications liées à l’utilisation périopératoire des médicaments antidépresseurs

  2011cites this paper
• Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?

  2011cites this paper
• Dapoxetine for premature ejaculation

  2010cites this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Article Crossroads of Pain and Addiction

  2010cites this paper
• Pharmacological treatment of obsessive-compulsive disorder.

  2010cites this paper
• Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity.

  2010cites this paper
• The pharmacological properties of antidepressants

  2010cites this paper
• [Long-term course of treatment strategies in panic disorder: an update narrative review 1999-2010].

  2010cites this paper
• Crossroads of pain and addiction.

  2010cites this paper
• Absetz- und Toleranzphänomene bei Antidepressiva

  2010cites this paper
• Nocturnal sleep disturbances as a predictor of suicide attempts among psychiatric outpatients: a clinical, epidemiologic, prospective study.

  2010cites this paper
• Effects of the Serotonin 1A, 2A, 2C, 3A, and 3B and Serotonin Transporter Gene Polymorphisms on the Occurrence of Paroxetine Discontinuation Syndrome

  2010cites this paper
• 35 – Psychopharmacological Management of Children and Adolescents

  2010cites this paper
• Thermodynamic laws apply to brain function.

  2010cites this paper
• Pharmacotherapy and psychotherapy of pediatric depression

  2010cites this paper
• Discontinuation Symptoms and SSRIs

  2009cites this paper
• [SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine].

  2009cites this paper
• Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder

  2009cites this paper
• Serotonin: modulator of a drive to withdraw.

  2009cites this paper
• Pain and Addictive Disorders: Challenge and Opportunity

  2008cites this paper
• Pharmacological management of panic disorder

  2008cites this paper
• Long-term side effects of adjuvant breast cancer treatment

  2008cites this paper